Intel’s 4% surge throws a gauntlet at nvidia’s gtc party
Intel’s battered stock snapped four weeks of lethargy Monday, leaping 4.4% in heavy volume while rival Nvidia preened on the eve of its GTC conference. The move felt almost defiant: a chipmaker left for dead suddenly flashing signs of life just as the AI kingdom prepares to crown its next-gen GPU monarch.
A quiet alliance with ericsson and infosys
The spark came from two low-key press releases posted before dawn. First, Ericsson will fold Intel’s 18A process into future 6G radios, betting that the angstrom-scale node can crank enough AI horsepower inside a base-station antenna. Second, Infosys will port Intel’s Health & Life Sciences AI Suite to hospitals in Bangalore and Houston, turning X-ray machines into edge-learning nodes. Neither deal carries a headline dollar figure, yet traders treated them as receipts for a foundry strategy that finally has buyers.
Intel’s foundry division has spent two years begging for external customers; now it can name two. The stock cracked through the 50-day moving average for the first time since January, a technical wink that algorithmic funds read as permission to cover shorts.
Gtc halo lifts the whole sandbox
Across town, Nvidia CEO Jensen Huang rehearsed a keynote that will lavish 90 minutes on Blackwell GPUs and quantum-dotted switches. Semi investors, allergic to missing whatever comes next, poured fresh money into the sector: the PHLX SOX index tacked on 3%, its best day since October. Intel’s booth at GTC—tucked between quantum startups and a coffee stand—became an unlikely selfie stop. Engineers crowded around a PCIe card bristling with Gaudi 3 accelerators, the company’s answer to Nvidia’s H100. The card runs stable at 1,835 watts, hot enough to double as a hand warmer in San Jose’s spring fog.
Meta added its own accelerant, confirming an order for “millions” of Nvidia B200 GPUs to power Llama 4. The announcement shoved Meta shares up 2.7% and reminded Wall Street that the AI arms race still has only one arms dealer—unless Intel can ship Gaudi fast enough to matter.
Embedded world revealed core series 2
While GTC sizzle reels looped, Intel’s embedded team dropped Core Ultra Series 2 processors in Nuremberg. The chips stitch together Redwood Cove P-cores, Crestmont E-cores, and a fused NPU that can spit 34 TOPS at 15 watts. In plain language: a rugged tablet can now runStable Diffusion offline inside an ambulance. Early benchmarks show 1.9× the AI throughput of AMD’s Ryzen Embedded V3000 at the same wattage, a delta that industrial OEMs notice before retail consumers do.
Health & Life Sciences AI Suite, the software layer unveiled alongside the hardware, turns those TOPS into diagnostic prompts. A pilot at MD Anderson cut radiologist queue times by 22%, according to internal data shared with TechFlux. Intel won’t charge hospitals for the software; it plans to monetize the cloud instances that retrain the models on new tumor scans. Call it the razor-and-blade gambit, except the razor is a $4000 COM Express module.
Monday’s rally pushed Intel’s year-to-date loss to 8%, still ugly but no longer catastrophic. More importantly, open interest in April 50 calls exploded to 42,000 contracts, bets that the stock can top $50 within five weeks. The last time options traders piled in this aggressively, Pat Gelsinger had just unveiled IDM 2.0; the shares slid 19% the following month.
This time the narrative smells different—not of turnaround promises but of purchase orders, however small. Foundry customers, edge AI wins, a GTC cameo: tiny tiles in a mosaic that Intel must now grout with execution. Miss one quarterly yield target and the 4% pop becomes another false dawn. Nail yield, and the crown prince of CPUs might yet gate-crash Nvidia’s AI ball.